ESR1 and breast cancer: Mast cells have been reported to stimulate estrogen receptor activity in breast cancer cells, which promoted the luminal phenotype, the less aggressive cancer types, and possibly explained the association between a higher mast cell infiltration and a better disease prognosis (48, 49).